NHS meningitis B vaccination scheme begins in U.K.

The British Joint Committee on Vaccination and Immunisation recommended that a meningitis B jab be added to the routine childhood vaccination schedule. But thanks to pricing negotiations, the administration of GlaxoSmithKline's ($GSK)--formerly Novartis' ($NVS)--Bexsero to babies aged two months, four months and 12-13 months began just this week. More

Suggested Articles

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Sanofi's cost cuts are adding up, execs said in an update Wednesday. The company has trimmed nearly €1 billion in annual expenses so far in 2020.

Shingrix sales in the second quarter plummeted by half from first-quarter levels, and recovery of vaccination rates remains slow amid the pandemic.